FeesSafety
Pluang+

Chinese AI startup DeepSeek plans $7.4B funding round, valuing it up to $59B with Tencent and CATL backing.

Market News
03 Jun 2026, 15:45 WIB
Ananya Gairola
View Source
Bullish
Chinese AI startup DeepSeek plans $7.4B funding round, valuing it up to $59B with Tencent and CATL backing.

Chinese AI startup DeepSeek is preparing to raise about $7.4 billion in its first external funding round, potentially valuing the company between $51 billion and $59 billion. Major investors expected to participate include Tencent, which may invest around 10 billion yuan, and battery maker CATL, considering a 5 billion yuan commitment. The fundraising round could close within weeks, with founder Liang Wenfeng personally contributing 20 billion yuan. DeepSeek has gained international recognition for its AI models, challenging assumptions about China's AI capabilities, and this funding will support its growth and innovation.

More News

Danske Bank buys back 25,000 shares in week 46, continuing its DKK 4.5 billion buy-back program.

Danske Bank buys back 25,000 shares in week 46, continuing its DKK 4.5 billion buy-back program.

Danske Bank executed transactions to repurchase 25,000 shares during week 46 as part of its ongoing share buy-back program announced in February 2026. The program targets a total buy-back of up to DKK 4.5 billion or 45 million shares by January 2027....

Company Fundamentals
Neutral
18 minutes ago
French firms boost AI-driven cybersecurity, focusing on productivity and operational results over processes.

French firms boost AI-driven cybersecurity, focusing on productivity and operational results over processes.

A new study by Securonix shows French organizations are increasingly adopting AI-driven cybersecurity operations, prioritizing productivity and measurable outcomes rather than just processes. French firms lead in allowing AI to automatically trigger ...

Market News
Neutral
1 hour ago
Lakefront Biotherapeutics launches new €50M share buyback after completing initial program

Lakefront Biotherapeutics launches new €50M share buyback after completing initial program

Lakefront Biotherapeutics has started a new €50 million share buyback program following the completion of its initial €50 million program, in which it repurchased about 1.99 million shares. The new program, running until March 31, 2027, aims to enhan...

Company Fundamentals
Bullish
2 hours ago
Exosens wins order for 25,000 image intensifier tubes to boost European night vision tech.

Exosens wins order for 25,000 image intensifier tubes to boost European night vision tech.

Exosens secured a firm order to supply 25,000 high-performance 4G+ image intensifier tubes to Theon Sensors for integration into night vision devices, with deliveries starting late 2026. This order is part of a long-term agreement through 2030 and in...

Market News
Bullish
3 hours ago
Exosens secures a major order for 25,000 light intensifier tubes for night vision devices through 2030.

Exosens secures a major order for 25,000 light intensifier tubes for night vision devices through 2030.

Exosens has received a firm order for 25,000 high-performance 4G+ light intensifier tubes to equip night vision products for Theon, under a long-term supply agreement extended through 2030. The order includes options for an additional 35,000 tubes, p...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App